EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive study tracks Long-Term effects of rare disease drug
Disease control CompletedThis study monitored the long-term safety and effectiveness of NUCALA injections for people with EGPA, a rare autoimmune disease. It followed over 4,000 patients for up to two years while they received the drug in real-world settings. The goal was to collect information on side e…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Trial tests new hope for controlling rare, relapsing autoimmune disease
Disease control CompletedThis study tested whether the drug rituximab is better than the standard drug azathioprine at keeping a rare autoimmune disease called EGPA in remission. It involved 98 adults whose disease had recently been brought under control. The goal was to see which drug helped patients st…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC